Centene Corporation (CNC) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $37.25. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CNC = $1,904.59 (+5013% from the current price, the stock appears undervalued). Analyst consensus target is CNC = $45 (+20.5% upside).
Valuation: CNC trades at a trailing Price-to-Earnings (P/E) of -2.7 (S&P 500 average ~25).
Financials: revenue is $194.8B, +10.6%/yr average growth. Net income is $6.7B (loss), growing at -51.6%/yr. Net profit margin is -3.4% (negative). Gross margin is 12.2% (+0.7 pp trend).
Balance sheet: total debt is $18.8B against $20.0B equity (Debt-to-Equity (D/E) ratio 0.94, moderate). Current ratio is 1.68 (strong liquidity). Debt-to-assets is 24.2%. Total assets: $77.7B.
Analyst outlook: 24 / 43 analysts rate CNC as buy (56%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 86/100 (Pass), Growth 48/100 (Partial), Past 75/100 (Partial), Health 50/100 (Partial), Moat 56/100 (Partial), Future 58/100 (Partial), Income 10/100 (Fail).
